Skip to main content
    C

    Cencora Inc. (COR)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $357.08
    -1.95 (-0.54%)

    Market Cap: $68.51B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cencora Inc. (COR) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Cencora (COR) trades at 19.9x trailing earnings and 0.2x sales. Its P/E of 19.9x is above its 5-year median of 16.6x. Its forward P/E is 18.3x. The median P/E across 11 similar companies is 25.5x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 8.7% higher over the next year. Its free cash flow yield is 5.9%.

    MultipleValue
    P/E (trailing)19.9x
    Forward P/E18.3x
    Price to sales0.2x
    Price to book22.6x
    EV/EBITDA15.3x
    Price to FCF17.0x
    EV/FCF19.2x
    PEG0.8
    FCF yield5.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 38.2% above 14.4x, its P/S is 100.0% above 0.1x and its P/B is 10.2% above 20.5x.

    MultipleCurrent5-year median10-year median
    P/E19.9x16.6x14.4x
    P/S0.2x0.2x0.1x
    P/B22.6x52.6x20.5x
    Medians of month-end values through Oct 2026: 54 to 60 months (5-year) and 105 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 11.4x in 2018 to 20.7x in 2025. 2025 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$337.7520.7x0.2x34.4x
    2024$224.6815.8x0.1x192.1x
    2023$205.3816.4x0.2x45.1x
    2022$165.7114.9x0.1xN/A
    2021$132.8913.8x0.1x114.7x
    2020$97.7611.8x0.1xN/A
    2019$85.0211.7xN/A5.9x
    2018$74.4011.4xN/A5.2x
    2017$91.8215.1x0.1x7.0x
    2016$78.1913.7x0.1x8.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About COR

    What is COR's forward P/E ratio?

    Cencora has a forward P/E ratio of 18.3x.

    Is COR stock overvalued?

    GNG's valuation label for COR is Undervalued. Its P/E of 19.9x compares with a median of 25.5x across 11 similar companies.

    What is COR's price to sales ratio?

    Cencora has a price to sales ratio of 0.2x.

    What is Cencora's average P/E ratio over 5 years?

    Cencora's median P/E over the last 5 years is 16.6x, from 60 month-end values through Oct 2026.

    What is COR's PEG ratio?

    Cencora has a PEG ratio of 0.8.